The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease.
作者信息
Song Do Seon
机构信息
Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Gut Liver. 2024 Jul 15;18(4):562-563. doi: 10.5009/gnl240200.
Abstract
摘要
相似文献
1
The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver Disease.身体成分对非酒精性脂肪性肝病预后的影响
Gut Liver. 2024 Jul 15;18(4):562-563. doi: 10.5009/gnl240200.
2
Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.钠-葡萄糖共转运蛋白 2 抑制剂对 2 型糖尿病合并非酒精性脂肪性肝病患者肝脂肪量和身体成分的影响。
Clin Drug Investig. 2019 Jul;39(7):631-641. doi: 10.1007/s40261-019-00785-6.
3
Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?酒精性和非酒精性脂肪性肝病中的肝细胞癌是同一种疾病吗？
Gastroenterology. 2016 Jun;150(8):1710-7. doi: 10.1053/j.gastro.2016.01.006. Epub 2016 Jan 16.
4
Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.身体成分与非酒精性脂肪性肝病组织学之间的关系：一项横断面研究。
BMC Gastroenterol. 2021 Apr 13;21(1):170. doi: 10.1186/s12876-021-01748-y.
5
Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?消瘦或非肥胖型非酒精性脂肪性肝病患者：他们真的消瘦吗？
Clin Mol Hepatol. 2023 Oct;29(4):980-983. doi: 10.3350/cmh.2023.0250. Epub 2023 Aug 16.
6
Nonalcoholic fatty liver and the severity of acute pancreatitis.非酒精性脂肪肝与急性胰腺炎的严重程度。
Eur J Intern Med. 2017 Mar;38:73-78. doi: 10.1016/j.ejim.2016.10.019. Epub 2016 Nov 5.
7
Fibrosis in nonalcoholic Fatty liver disease: mechanisms and clinical implications.非酒精性脂肪性肝病中的纤维化：机制与临床意义
Semin Liver Dis. 2015 May;35(2):132-45. doi: 10.1055/s-0035-1550065. Epub 2015 May 14.
8
Nonalcoholic Fatty Liver Disease-Evidence for a Thrombophilic State?非酒精性脂肪性肝病——存在血栓形成倾向？
Curr Pharm Des. 2020;26(10):1036-1044. doi: 10.2174/1381612826666200131101553.
9
Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease.卡格列净对非酒精性脂肪性肝病 2 型糖尿病患者的体成分和肝脂肪含量的影响。
J Diabetes Investig. 2019 Jul;10(4):1004-1011. doi: 10.1111/jdi.12980. Epub 2019 Jan 4.
10
Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病肥胖儿童的维生素D状况与骨密度
J Korean Med Sci. 2015 Dec;30(12):1821-7. doi: 10.3346/jkms.2015.30.12.1821. Epub 2015 Nov 30.
本文引用的文献
1
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.附肢骨骼肌质量与内脏脂肪面积比值预测肝脏疾病。
Gut Liver. 2024 May 15;18(3):509-519. doi: 10.5009/gnl230238. Epub 2023 Nov 28.
2
Changing epidemiology, global trends and implications for outcomes of NAFLD.非酒精性脂肪性肝病的流行病学变化、全球趋势及其对结局的影响。
J Hepatol. 2023 Sep;79(3):842-852. doi: 10.1016/j.jhep.2023.04.036. Epub 2023 May 9.
3
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.非酒精性脂肪性肝病肝纤维化的无创性影像学生物标志物：现状与展望。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S136-S149. doi: 10.3350/cmh.2022.0436. Epub 2022 Dec 12.
4
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者死亡的原因和风险概况。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S43-S57. doi: 10.3350/cmh.2022.0351. Epub 2022 Nov 22.
5
Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression.肌肉脂肪变性而非肌肉减少症使非酒精性脂肪性肝病患者易发生早期脂肪性肝炎和纤维化进展。
Clin Gastroenterol Hepatol. 2023 Feb;21(2):388-397.e10. doi: 10.1016/j.cgh.2022.01.020. Epub 2022 Jan 31.
6
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病成人患者结局的前瞻性研究。
N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349.
7
Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey.肌肉力量与非酒精性脂肪性肝病肝纤维化程度的相关性：一项韩国全国性调查。
J Cachexia Sarcopenia Muscle. 2020 Oct;11(5):1232-1241. doi: 10.1002/jcsm.12598. Epub 2020 Jul 7.
8
Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.系统评价与荟萃分析：非酒精性脂肪性肝病瘦型患者组织学疾病严重程度的意义。
Aliment Pharmacol Ther. 2018 Jan;47(1):16-25. doi: 10.1111/apt.14401. Epub 2017 Oct 30.
9
Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.肌肉减少症是非酒精性脂肪性肝炎和显著纤维化的独立危险因素。
J Hepatol. 2017 Jan;66(1):123-131. doi: 10.1016/j.jhep.2016.08.019. Epub 2016 Sep 4.
10
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.非酒精性脂肪肝与非酒精性脂肪性肝炎的纤维化进展：配对活检研究的系统评价和荟萃分析
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40. doi: 10.1016/j.cgh.2014.04.014. Epub 2014 Apr 24.
Zotero 插件